Arthritis is a leading cause of disability in the United States. Despite its prevalence in our ever-aging society, effective treatment options for arthritis are still limited. Arthritis is caused by the destruction of joint cartilage, which is accompanied by inflammation and pain. Cartilage tissue engineering offers a promising solution to regenerate cartilage and restore tissue function. However, the presence of pro-inflammatory cytokines at the host site inevitably leads to matrix degradation, causing the engineered cartilage to be unstable. Therefore, for this technology to be applied clinically there is a critical need to engineer stable cartilage that is resistant to pro-inflammatory cytokine-induced degradation. Our long-term goal is to gain critical knowledge of cartilage regulation and enhance the technology of cartilage tissue engineering for clinical applications. We are developing a novel strategy that integrates concepts and approaches from developmental biology with those of tissue engineering. During embryogenesis, muscle is one of the tissues that develop alongside the presumptive cartilage tissue. Our extensive preliminary studies indicate a role of muscle cells in regulating cartilage homeostasis and inflammatory stimuli. Our central hypothesis is that muscle cells and optimal scaffold selection can be used to enhance the stability of engineered cartilage by enhancing cartilage matrix production and the resistance to pro-inflammatory cytokines. We plan to test this hypothesis by using primary human articular chondrocytes and mesenchymal stem cells seeded in 3D silk scaffolds. We plan to: 1) investigate the role of muscle cells in regulating cartilage matrix production, 2) investigate the role of muscle cells in regulating the response to pro-inflammatory cytokines, and 3) investigate the effect of scaffold material on muscle cell regulation of cartilage matrix production and the response to pro-inflammatory cytokines. Our research team consists of experts in the fields of developmental biology, tissue engineering, immunology and orthopaedics. We believe that our synergistic efforts and interdisciplinary approach will result in deeper understanding of the regulation of cartilage homeostasis and the response to pro- inflammatory stimuli, providing the fundamental knowledge for modeling and treating arthritis. Thus, our study aspires to meet the critical need of improving tissue engineering technology, and may lead to the development of a novel strategy to engineer stable cartilage for clinical applications.
Arthritis, characterized by inflammation and joint destruction, is a leading cause of disability in our ever-aging society. However, effective treatment options for this prevailing disease still remain limited. We propose a novel strategy to engineer stable cartilage tissue that is resistant to inflammation by utilizing muscle cells. Thus, our research aspires to meet the critical need for improving cartilage regeneration and joint repair technology, which may ultimately be developed as an effective treatment method for arthritis.
|Hui Mingalone, Carrie K; Liu, Zhiyi; Hollander, Judith M et al. (2018) Bioluminescence and second harmonic generation imaging reveal dynamic changes in the inflammatory and collagen landscape in early osteoarthritis. Lab Invest 98:656-669|
|Gibson, Averi L; Hui Mingalone, Carrie K; Foote, Andrea T et al. (2017) Wnt7a Inhibits IL-1? Induced Catabolic Gene Expression and Prevents Articular Cartilage Damage in Experimental Osteoarthritis. Sci Rep 7:41823|
|Uchimura, Tomoya; Foote, Andrea T; Markel, David C et al. (2016) The Chondroprotective Role of Erythromycin in a Murine Joint Destruction Model. Cartilage 7:373-87|
|Tang, X; Fan, L; Pei, M et al. (2015) Evolving concepts of chondrogenic differentiation: history, state-of-the-art and future perspectives. Eur Cell Mater 30:12-27|
|Kwon, Heenam; Rainbow, Roshni S; Sun, Lin et al. (2015) Scaffold structure and fabrication method affect proinflammatory milieu in three-dimensional-cultured chondrocytes. J Biomed Mater Res A 103:534-44|
|Uchimura, Tomoya; Foote, Andrea T; Smith, Eric L et al. (2015) Insulin-Like Growth Factor II (IGF-II) Inhibits IL-1?-Induced Cartilage Matrix Loss and Promotes Cartilage Integrity in Experimental Osteoarthritis. J Cell Biochem 116:2858-69|
|Leahy, Averi A; Esfahani, Shadi A; Foote, Andrea T et al. (2015) Analysis of the trajectory of osteoarthritis development in a mouse model by serial near-infrared fluorescence imaging of matrix metalloproteinase activities. Arthritis Rheumatol 67:442-53|
|Rainbow, Roshni S; Won, Heenam K; Zeng, Li (2014) The role of Nkx3.2 in chondrogenesis. Front Biol (Beijing) 9:376-381|
|Cairns, Dana M; Pignolo, Robert J; Uchimura, Tomoya et al. (2013) Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia. J Clin Invest 123:3624-33|
|Kwon, Heenam; Sun, Lin; Cairns, Dana M et al. (2013) The influence of scaffold material on chondrocytes under inflammatory conditions. Acta Biomater 9:6563-75|
Showing the most recent 10 out of 16 publications